Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study

被引：5

作者：

Paschou, Stavroula A. ^{[1
]}

Karalis, Vangelis ^{[2
]}

Psaltopoulou, Theodora ^{[3
]}

Charitaki, Ioanna ^{[3
]}

Sklirou, Aimilia D. ^{[4
]}

Iconomidou, Vassiliki A. ^{[4
]}

Vasileiou, Vasiliki ^{[5
]}

Kassi, Georgia N. ^{[5
]}

Vryonidou, Andromachi ^{[6
,7
]}

Kokkinos, Alexander ^{[8
]}

Tentolouris, Nicholas ^{[8
]}

Hatziaggelaki, Erifili ^{[9
]}

Trougakos, Ioannis P. ^{[4
]}

Terpos, Evangelos ^{[3
]}

Dimopoulos, Meletios Athanasios ^{[3
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Endocrine Unit & Diabet Ctr,Dept Clin Therapeut, Athens, Greece

[2] Natl & Kapodistrian Univ Athens, Sch Hlth Sci, Fac Pharm, Athens, Greece

[3] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, 80 Vasilisis Sophias Ave, Athens 11528, Greece

[4] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece

[5] Alexandra Hosp, Dept Endocrinol, Athens, Greece

[6] Hellen Red Cross Hosp, Dept Endocrinol, Athens, Greece

[7] Hellen Red Cross Hosp, Diabet Ctr, Athens, Greece

[8] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut Internal Med 1, Diabet Ctr, Athens, Greece

[9] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Diabet Ctr, Athens, Greece

来源：

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2023年 / 22卷 / 01期

关键词：

Type; 2; diabetes; Diabetes mellitus; Hyperglycemia; Vaccination; COVID-19; Immune response; SARS-CoV-2; ENDOCRINE;

D O I：

10.1007/s42000-022-00405-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aim To compare the kinetics of neutralizing antibodies (N Alpha bs) against SARS-CoV-2 after vaccination with the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech) between patients with T2DM and healthy controls. Methods NAb levels after the BNT162b2 mRNA vaccine were compared between 50 patients with non-insulin treated T2DM and 50 age-, gender-, and BMI-matched healthy controls up to 3 months after the second dose. The median age of both groups was 70 years. Results On day 1, mean NAbs of the control and T2DM groups were 14.64% (standard error, SE = 2.30) and 14.04% (SE = 2.14), respectively (p value = 0.926). Three weeks later, the mean NAb values were 39.98% (SE = 3.53) in the control group and 40.97% (SE = 3.99) in participants with T2DM (p value = 0.698). One month after the second vaccination, mean NAb values increased to 87.13% (SE = 2.94) in the control group and 89.00% (SE = 2.18) in the T2DM group. Three months after the second vaccine dose, the mean inhibitory titers decreased to 83.49% (SE = 3.82) (control group) and 76.36% (SE = 3.33) (T2DM group). On all occasions, no significant difference was found between the two groups (all p values > 0.05). Conclusions Patients with T2DM present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to that of healthy subjects.

引用

页码：5 / 11

页数：7

共 24 条

[1] Characteristics and outcomes ofCOVID-19 in hospitalized patients with and without diabetes [J].

Al-Salameh, Abdallah ;

Lanoix, Jean-Philippe ;

Bennis, Youssef ;

Andrejak, Claire ;

Brochot, Etienne ;

Deschasse, Guillaume ;

Dupont, Herve ;

Goeb, Vincent ;

Jaureguy, Maite ;

Lion, Sylvie ;

Maizel, Julien ;

Moyet, Julien ;

Vaysse, Benoit ;

Desailloud, Rachel ;

Ganry, Olivier ;

Schmit, Jean-Luc ;

Lalau, Jean-Daniel .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (03)

[2] Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination [J].

Ali, Hamad ;

Alterki, Abdulmohsen ;

Sindhu, Sardar ;

Alahmad, Barrak ;

Hammad, Maha ;

Al-Sabah, Salman ;

Alghounaim, Mohammad ;

Jamal, Mohammad H. ;

Aldei, Ali ;

Mairza, Mohammad J. ;

Husain, Maitham ;

Deverajan, Sriraman ;

Ahmad, Rasheed ;

Cherian, Preethi ;

Alkhairi, Irina ;

Alkandari, Abdullah ;

Abubaker, Jehad ;

Abu-Farha, Mohamed ;

Al-Mulla, Fahd .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[3] Managing diabetes in ageing patients during the COVID-19 pandemic [J].

Armeni, Eleni ;

Paschou, Stavroula A. ;

Peppa, Melpomeni .

MATURITAS, 2021, 145 :89-90

[4] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].

Baden, Lindsey R. ;

El Sahly, Hana M. ;

Essink, Brandon ;

Kotloff, Karen ;

Frey, Sharon ;

Novak, Rick ;

Diemert, David ;

Spector, Stephen A. ;

Rouphael, Nadine ;

Creech, C. Buddy ;

McGettigan, John ;

Khetan, Shishir ;

Segall, Nathan ;

Solis, Joel ;

Brosz, Adam ;

Fierro, Carlos ;

Schwartz, Howard ;

Neuzil, Kathleen ;

Corey, Larry ;

Gilbert, Peter ;

Janes, Holly ;

Follmann, Dean ;

Marovich, Mary ;

Mascola, John ;

Polakowski, Laura ;

Ledgerwood, Julie ;

Graham, Barney S. ;

Bennett, Hamilton ;

Pajon, Rolando ;

Knightly, Conor ;

Leav, Brett ;

Deng, Weiping ;

Zhou, Honghong ;

Han, Shu ;

Ivarsson, Melanie ;

Miller, Jacqueline ;

Zaks, Tal .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416

[5]

Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]

[6] Clinical Characteristics of Coronavirus Disease 2019 in China [J].

Guan, W. ;

Ni, Z. ;

Hu, Yu ;

Liang, W. ;

Ou, C. ;

He, J. ;

Liu, L. ;

Shan, H. ;

Lei, C. ;

Hui, D. S. C. ;

Du, B. ;

Li, L. ;

Zeng, G. ;

Yuen, K. -Y. ;

Chen, R. ;

Tang, C. ;

Wang, T. ;

Chen, P. ;

Xiang, J. ;

Li, S. ;

Wang, Jin-lin ;

Liang, Z. ;

Peng, Y. ;

Wei, L. ;

Liu, Y. ;

Hu, Ya-hua ;

Peng, P. ;

Wang, Jian-ming ;

Liu, J. ;

Chen, Z. ;

Li, G. ;

Zheng, Z. ;

Qiu, S. ;

Luo, J. ;

Ye, C. ;

Zhu, S. ;

Zhong, N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) :1708-1720

[7] Early and late endocrine complications of COVID-19 [J].

Kazakou, Paraskevi ;

Paschou, Stavroula A. ;

Psaltopoulou, Theodora ;

Gavriatopoulou, Maria ;

Korompoki, Eleni ;

Stefanaki, Katerina ;

Kanouta, Fotini ;

Kassi, Georgia N. ;

Dimopoulos, Meletios-Athanasios ;

Mitrakou, Asimina .

ENDOCRINE CONNECTIONS, 2021, 10 (09) :R229-R239

[8] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection [J].

Khoury, David S. ;

Cromer, Deborah ;

Reynaldi, Arnold ;

Schlub, Timothy E. ;

Wheatley, Adam K. ;

Juno, Jennifer A. ;

Subbarao, Kanta ;

Kent, Stephen J. ;

Triccas, James A. ;

Davenport, Miles P. .

NATURE MEDICINE, 2021, 27 (07) :1205-+

[9] BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers [J].

Lustig, Yaniv ;

Sapir, Einav ;

Regev-Yochay, Gili ;

Cohen, Carmit ;

Fluss, Ronen ;

Olmer, Liraz ;

Indenbaum, Victoria ;

Mandelboim, Michal ;

Doolman, Ram ;

Amit, Sharon ;

Mendelson, Ella ;

Ziv, Arnona ;

Huppert, Amit ;

Rubin, Carmit ;

Freedman, Laurence ;

Kreiss, Yitshak .

LANCET RESPIRATORY MEDICINE, 2021, 9 (09) :999-1009

[10] Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study [J].

Papadokostaki, Eleni ;

Tentolouris, Anastasios ;

Anastasiou, Ioanna A. ;

Psichogiou, Mina ;

Iliaki, Evangelia ;

Eleftheriadou, Ioanna ;

Hatzakis, Angelos ;

Tentolouris, Nikolaos .

VACCINES, 2022, 10 (03)

← 1 2 3 →